@article {Luykx2020.11.29.20240481, author = {Jurjen J. Luykx and Bochao D. Lin}, title = {Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable and multivariable Mendelian Randomization study}, elocation-id = {2020.11.29.20240481}, year = {2020}, doi = {10.1101/2020.11.29.20240481}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Importance Observational studies have suggested bidirectional associations between psychiatric disorders and COVID-19 phenotypes, but results of such studies are inconsistent. Mendelian Randomization (MR) may overcome limitations of observational studies, e.g. unmeasured confounding and uncertainties about cause and effect.Objective To elucidate associations between neuropsychiatric disorders and COVID-19 susceptibility and severity.Method In November, 2020, we applied a two-sample, bidirectional, univariable and multivariable MR design to genetic data from genome-wide association studies (GWASs) of neuropsychiatric disorders and COVID-19 phenotypes (released on 20 Oct. 2020). Our study population consisted of almost 2 million participants with either a (neuro)psychiatric disorder or data on COVID-19 status. Outcomes and exposures were anxiety, anxiety-and-stress related disorders, major depressive disorder, schizophrenia, bipolar disorder, schizophrenia-bipolar disorder combined (BIP-SCZ), and Alzheimer{\textquoteright}s dementia on the one hand; and self-reported, confirmed, hospitalized, and very severe COVID-19 on the other.Results In single-variable MR analysis the most significant and only Bonferroni-corrected significant result was found for BIP-SCZ (a combined anxiety of bipolar disorder and schizophrenia as cases vs. controls): the effect estimate was consistent with increased risk of COVID-19 (OR = 1.17, 95\% CI, 1.06-1.28; p = 0.0012). Nominally significant univariable results were in line with slightly elevated risks of COVID-19 for genetic liabilities to bipolar disorder and schizophrenia. No COVID-19 phenotype consistently increased risk of (neuro)psychiatric disorders. In multivariable MR, bipolar disorder was the only phenotype showing a Bonferroni-corrected significant effect on a COVID-19 phenotype, namely severe COVID-19 (OR = 1.293; 95\% CI, 1.095-1.527; p = 0.003). All sensitivity analyses confirmed the results.Conclusions Genetic liability to bipolar disorder slightly increases COVID-19 susceptibility and severity. The contribution of bipolar disorder to these COVID-19 phenotypes was smaller than the odds ratios estimated by observational studies. Strength of association and direction of effect for genetic liability to schizophrenia were similar, albeit less significant. We found no consistent evidence of reverse effects, i.e. of genetic liability to COVID-19 on psychiatric disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GWAS summary statistics we used were drawn from studies that had obtained written informed consent from participants and received ethical approval from institutional review boards. No ethical approval for the current analyses was needed as they were based on publicly available summary statistics.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code availability We have made our code publicly available on Github (https://github.com/Bochao1/MR_PSY_COVID19). The datasets we accessed to perform our analyses may be found in the publications that listed as references for the datasets used.}, URL = {https://www.medrxiv.org/content/early/2020/11/30/2020.11.29.20240481}, eprint = {https://www.medrxiv.org/content/early/2020/11/30/2020.11.29.20240481.full.pdf}, journal = {medRxiv} }